Background/Aim: Gesturing plays an important role in social behavior and social learning. Deficits are frequent in schizophrenia and may contribute to impaired social functioning. Information about deficits during the course of the disease and presence of severity and patterns of impairment in first-episode patients is missing. Hence, we aimed to investigate gesturing in first- compared to multiple-episode schizophrenia patients and healthy controls. Methods: In 14 first-episode patients, 14 multiple-episode patients and 16 healthy controls matched for age, gender and education, gesturing was assessed by the comprehensive Test of Upper Limb Apraxia. Performance in two domains of gesturing - imitation and pantomime - was recorded on video. Raters of gesture performance were blinded. Results: Patients with multiple episodes had severe gestural deficits. For almost all gesture categories, performance was worse in multiple- than in first-episode patients. First-episode patients demonstrated subtle deficits with a comparable pattern. Conclusions: Subjects with multiple psychotic episodes have severe deficits in gesturing, while only mild impairments were found in first-episode patients independent of age, gender, education and negative symptoms. The results indicate that gesturing is impaired at the onset of disease and likely to further deteriorate during its course.

1.
Cornblatt BA, Auther AM, Niendam T, Smith CW, Zinberg J, Bearden CE, et al: Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull 2007;33:688-702.
2.
Couture SM, Penn DL, Roberts DL: The functional significance of social cognition in schizophrenia: a review. Schizophr Bull 2006;32(suppl 1):S44-S63.
3.
Penn DL, Sanna LJ, Roberts DL: Social cognition in schizophrenia: an overview. Schizophr Bull 2008;34:408-411.
4.
Kalkstein S, Hurford I, Gur RC: Neurocognition in schizophrenia. Curr Top Behav Neurosci 2010;4:373-390.
5.
Borod JC, Welkowitz J, Alpert M, Brozgold AZ, Martin C, Peselow E, et al: Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of tests. J Commun Disord 1990;23:247-271.
6.
Toomey R, Schuldberg D, Corrigan P, Green MF: Nonverbal social perception and symptomatology in schizophrenia. Schizophr Res 2002;53:83-91.
7.
Lavelle M, Healey PG, McCabe R: Nonverbal behavior during face-to-face social interaction in schizophrenia: a review. J Nerv Ment Dis 2014;202:47-54.
8.
Demirbuga S, Sahin E, Ozver I, Aliustaoglu S, Kandemir E, Varkal MD, et al: Facial emotion recognition in patients with violent schizophrenia. Schizophr Res 2013;144:142-145.
9.
Park S, Matthews N, Gibson C: Imitation, simulation, and schizophrenia. Schizophr Bull 2008;34:698-707.
10.
Beattie G, Shovelton H: Iconic hand gestures and the predictability of words in context in spontaneous speech. Br J Psychol 2000;91:473-491.
11.
Walther S, Mittal VA: Why we should take a closer look at gestures. Schizoph Bull 2016; 42:259-261.
12.
Obermeier C, Dolk T, Gunter TC: The benefit of gestures during communication: evidence from hearing and hearing-impaired individuals. Cortex 2012;48:857-870.
13.
Straube B, Meyer L, Green A, Kircher T: Semantic relation vs surprise: the differential effects of related and unrelated co-verbal gestures on neural encoding and subsequent recognition. Brain Res 2014;1567:42-56.
14.
Heyes C: Causes and consequences of imitation. Trends Cogn Sci 2001;5:253-261.
15.
Walther S, Vanbellingen T, Müri R, Strik W, Bohlhalter S: Impaired gesture performance in schizophrenia: particular vulnerability of meaningless pantomimes. Neuropsychologia 2013;51:2674-2678.
16.
Walther S, Vanbellingen T, Müri R, Strik W, Bohlhalter S: Impaired pantomime in schizophrenia: association with frontal lobe function. Cortex 2013;49:520-527.
17.
Walther S, Stegmayer K, Sulzbacher J, Vanbellingen T, Müri R, Strik W, et al: Nonverbal social communication and gesture control in schizophrenia. Schizophr Bull 2015;41:338-345.
18.
Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, et al: Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000;157:549-559.
19.
Pukrop R, Schultze-Lutter F, Ruhrmann S, Brockhaus-Dumke A, Tendolkar I, Bechdolf A, et al: Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. J Clin Exp Neuropsychol 2006;28:1388-1407.
20.
Marcus J, Hans SL, Lewow E, Wilkinson L, Burack CM: Neurological findings in high-risk children: childhood assessment and 5-year followup. Schizophr Bull 1985;11:85-100.
21.
Mittal VA, Tessner KD, Trottman HD, Esterberg M, Dhruv SH, Simeonova DI, et al: Movement abnormalities and the progression of prodromal symptomatology in adolescents at risk for psychotic disorders. J Abnorm Psychol 2007;116:260-267.
22.
Walker E, Lewine RJ: Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am J Psychiatry 1990;147:1052-1056.
23.
Peralta V, Cuesta MJ: Neuromotor abnormalities in neuroleptic-naive psychotic patients: antecedents, clinical correlates, and prediction of treatment response. Compr Psychiatry 2011;52:139-145.
24.
Peralta V, Campos MS, De Jalon EG, Cuesta MJ: Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders. Mov Disord 2010;25:1068-1076.
25.
Walther S, Strik W: Motor symptoms and schizophrenia. Neuropsychobiology 2012;66:77-92.
26.
Bilder RM, Bates JA: Neuropsychological prediction of treatment response and outcome in schizophrenia; in Gaebel W, Awad AG (eds): Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Vienna, Springer, 1994, pp 99-110.
27.
Bachmann S, Bottmer C, Schröder J: Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 2005;162:2337-2343.
28.
Millman ZBG, J, Schiffman J, Mejias J, Gupta T, Mittal VA: Mismatch and lexical retrieval gestures are associated with visual information processing, verbal production, and symptomatology in youth at high risk for psychosis. Schizophr Res 2014;158:64-68.
29.
Mittal VA, Tessner KD, McMillan AL, Delawalla Z, Trotman HD, Walker EF: Gesture behavior in unmedicated schizotypal adolescents. J Abnorm Psychol 2006;115:351-358.
30.
Oldfield RC: The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 1971;9:97-113.
31.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33; quiz 34-57.
32.
Woods SW: Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-667.
33.
Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull 1987;13:261-276.
34.
Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621-1626.
35.
Lund CE, Mortimer AM, Rogers D, McKenna PJ: Motor, volitional and behavioural disorders in schizophrenia. 1. Assessment using the Modified Rogers Scale. Br J Psychiatry 1991;158:323-327, 333-336.
36.
Guy W: ECDEU Assessment Manual for Psychopharmacology, revised ed. Washington, US Department of Health, Education, and Welfare, 1976.
37.
Fahn SE, Elton RL: Unified Parkinson's disease rating scale; in Fahn S, Marsden CD, Calne DB, Goldstein M (eds): Recent Developments in Parkinson's Disease. Florham Park, Macmillan Healthcare Information, 1987.
38.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
39.
Vanbellingen T, Kersten B, Van Hemelrijk B, Van de Winckel A, Bertschi M, Müri R, et al: Comprehensive assessment of gesture production: a new Test of Upper Limb Apraxia (TULIA). Eur J Neurol 2010;17:59-66.
40.
Cohen J: Statistical Power Analysis for the Behavioral Science, ed 2. Hillsdale, Erlbaum, 1988.
41.
Miller EK, Cohen JD: An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001;24:167-202.
42.
Stegmayer K, Bohlhalter S, Vanbellingen T, Federspiel A, Moor J, Wiest R, et al: Structural brain correlates of defective gesture performance in schizophrenia. Cortex 2016;78: 125-137.
43.
Quinn J, Meagher D, Murphy P, Kinsella A, Mullaney J, Waddington JL: Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction. Schizophr Res 2001;49:79-87.
44.
Mittal VA, Neumann C, Saczawa M, Walker EF: Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Arch Gen Psychiatry 2008;65:165-171.
45.
Matthews N, Gold BJ, Sekuler R, Park S: Gesture imitation in schizophrenia. Schizophr Bull 2013;39:94-101.
46.
Straube B, Green A, Sass K, Kircher T: Superior temporal sulcus disconnectivity during processing of metaphoric gestures in schizophrenia. Schizophr Bull 2014;40:936-944.
47.
Straube B, Green A, Sass K, Kirner-Veselinovic A, Kircher T: Neural integration of speech and gesture in schizophrenia: evidence for differential processing of metaphoric gestures. Hum Brain Mapp 2013;34:1696-1712.
48.
Dworkin RH, Cornblatt BA, Friedmann R, Kaplansky LM, Lewis JA, Rinaldi A, et al: Childhood precursors of affective vs social deficits in adolescents at risk for schizophrenia. Schizophr Bull 1993;19:563-577.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.